Advertisement

Chitosan nanoparticles from Artemia salina inhibit progression of hepatocellular carcinoma in vitro and in vivo

  • Mai M. Elkeiy
  • Abeer A. Khamis
  • Mona M. El-Gamal
  • Maha M. Abo Gazia
  • Zeinb A. Zalat
  • Mohammed A. El-Magd
Nanotechnology, Nanopollution, Nanotoxicology and Nanomedicine (NNNN)

Abstract

This study was conducted to evaluate the effect of chitosan nanoparticles (CNPs) isolated from Artemia salina against hepatocellular carcinoma (HCC) both in vitro (HepG2) and in vivo (diethylnitrosamine-induced HCC in rats) and to investigate the involved underlying mechanisms. Administration of CNPs decreased HCC progression as evidenced by (1) induced HepG2 cell death as detected by MTT assay; (2) induced necrosis as indicated by acridine orange/propidium iodide (AO/PI) red staining, annexin V/7-AAD positive staining (detected by flow cytometry), and upregulated expression of necrosis markers (PARP1 and its downstream target, RIP1 genes), but no effect on apoptosis as revealed by insignificant changes in caspase 3 activity and mRNA levels of Bax and AIF; (3) increased intracellular ROS and decreased mitochondrial membrane potential in HepG2; (4) decreased liver relative weight, serum levels of liver enzymes (ALT, AST, and ALP), total bilirubin, and cancer markers (AFP and GGT), number and area of GST-P positive tumor nodules; and (5) reduced oxidative stress (decrease in MDA levels) and increased activities of SOD, CAT, and GPx enzymes in rat liver. The preventive (pre-treatment) effect of CNPs was better than the therapeutic (post-treatment) effect. Collectively, administration of CNPs inhibited HCC progression in vitro and in vivo, possibly through induction of necrosis, rather than apoptosis, and induction of antioxidant enzyme activities in vivo, but with stimulation of ROS production in vitro. Thus, CNPs could be used as a promise agent for treating HCC after application of further confirmatory clinical trials.

Keywords

Chitosan nanoparticles Artemia salina Hepatocellular carcinoma Necrosis Oxidative stress 

Abbreviations

AIF

Apoptosis-inducing factor

ALP

Alkaline phosphatase

ALT

Alanine transaminase

ANOVA

Analysis of variance

AST

Aspartate transaminase

CAT

Catalase

DEN

Diethyl nitosoamine

GGT

γ-Glutamyl transferase

GPx

Glutathione peroxidase

HCC

Hepatocellular carcinoma;

MPT

Mitochondrial permeability transition

MMP

Mitochondrial membrane potential

PARP1

Poly(ADP-ribose) polymerase 1

RIP1

Serine/threonine kinases receptor interacting protein 1

SOD

Superoxide dismutase

THSD

Tukey’s honestly significant difference

References

  1. Abdelhadya DH, El-Magd MA, Elbialy ZI, Saleh AA, 2017 Bromuconazole-induced hepatotoxicity is accompanied by upregulation of PXR/CYP3A1 and downregulation of CAR/CYP2B1 gene expression. Toxicol Mech Methods 1–7Google Scholar
  2. Abdo W, Hirata A, Sakai H, El-Sawak A, Nikami H, Yanai T (2013) Combined effects of organochlorine pesticides heptachlor and hexachlorobenzene on the promotion stage of hepatocarcinogenesis in rats. Food Chem Toxicol 55:578–585CrossRefGoogle Scholar
  3. Abdulkarim A, Isa MT, Abdulsalam S, Muhammad AJ, Ameh AO, 2013. Extraction and characterisation of chitin and chitosan from mussel shell. Extraction 3Google Scholar
  4. Ajun W, Yan S, Li G, Huili L (2009) Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study. Carbohydr Polym 75:566–574CrossRefGoogle Scholar
  5. Douglas DL, Baines CP (2014) PARP1-mediated necrosis is dependent on parallel JNK and ca(2)(+)/calpain pathways. J Cell Sci 127:4134–4145CrossRefGoogle Scholar
  6. El-Denshary E, Aljawish A, El-Nekeety A, Hassan N, Saleh R, Rihn B, Abdel-Wahhab M (2015) Possible synergistic effect and antioxidant properties of chitosan nanoparticles and quercetin against carbon tetrachloride-induce hepatotoxicity in rats. Soft Nanoscience Letters 5:36–51CrossRefGoogle Scholar
  7. El-Magd MA, Abdo WS, El-Maddaway M, Nasr NM, Gaber RA, El-Shetry ES, Saleh AA, Alzahrani FAA, Abdelhady DH (2017a) High doses of S-methylcysteine cause hypoxia-induced cardiomyocyte apoptosis accompanied by engulfment of mitochondaria by nucleus. Biomed Pharmacother 94:589–597CrossRefGoogle Scholar
  8. El-Magd MA, Khalifa SF, Alzahrani FA, Badawy AA, El-Shetry ES, Dawood LM, Alruwaili MM, Alrawaili HA, Risha EF, El-Taweel FM, Marei HE (2018) Incensole acetate prevents beta-amyloid-induced neurotoxicity in human olfactory bulb neural stem cells. Biomed Pharmacother 105:813–823CrossRefGoogle Scholar
  9. El-Magd MA, Khamis A, Nasr Eldeen SK, Ibrahim WM, Salama AF (2017b) Trehalose enhances the antitumor potential of methotrexate against mice bearing Ehrlich ascites carcinoma. Biomed Pharmacother 92:870–878CrossRefGoogle Scholar
  10. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245–1255CrossRefGoogle Scholar
  11. Foster KA, Yazdanian M, Audus KL (2001) Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium. J Pharm Pharmacol 53:57–66CrossRefGoogle Scholar
  12. Huang G-J, Deng J-S, Chiu C-S, Liao J-C, Hsieh W-T, Sheu M-J, Wu C-H (2012) Hispolon protects against acute liver damage in the rat by inhibiting lipid peroxidation, proinflammatory cytokine, and oxidative stress and downregulating the expressions of iNOS, COX-2, and MMP-9. Evid Based Complement Alternat Med 2012:12Google Scholar
  13. Huang M, Khor E, Lim LY (2004) Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 21:344–353CrossRefGoogle Scholar
  14. Loh JW, Yeoh G, Saunders M, Lim L-Y (2010) Uptake and cytotoxicity of chitosan nanoparticles in human liver cells. Toxicol Appl Pharmacol 249:148–157CrossRefGoogle Scholar
  15. Loutfy S, Alam El-Din H, Elberry M, Allam N, Hasanin M, Abdellah A (2016) Synthesis, characterization and cytotoxic evaluation of chitosan nanoparticles: in vitro liver cancer model. Adv Nat Sci Nanosci Nanotechnol 7:035008CrossRefGoogle Scholar
  16. Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science (New York, NY) 311:622–627CrossRefGoogle Scholar
  17. Puvvada YS, Vankayalapati S, Sukhavasi S (2012) Extraction of chitin from chitosan from exoskeleton of shrimp for application in the pharmaceutical industry. Int Curr Pharm J 1:258–263CrossRefGoogle Scholar
  18. Qi L, Xu Z, Chen M (2007) In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. Eur J Cancer (Oxford, England 1990) 43:184–193CrossRefGoogle Scholar
  19. Qi LF, Xu ZR, Li Y, Jiang X, Han XY (2005) In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J Gastroenterol 11:5136–5141Google Scholar
  20. Subhapradha N, Shanmugam A (2017) Fabrication of β-chitosan nanoparticles and its anticancer potential against human hepatoma cells. Int J Biol Macromol 94:194–201CrossRefGoogle Scholar
  21. Subhapradha N, Shanmugam V, Shanmugam A (2017) Chitosan nanoparticles from marine squid protect liver cells against N-diethylnitrosoamine-induced hepatocellular carcinoma. Carbohydr Polym 171:18–26CrossRefGoogle Scholar
  22. Torchilin VP (2006) Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 24(1):1–16CrossRefGoogle Scholar
  23. Tsai GJ, Su WH (1999) Antibacterial activity of shrimp chitosan against Escherichia coli. J Food Prot 62:239–243CrossRefGoogle Scholar
  24. Wang H-Q, Sun X-B, Xu Y-X, Zhao H, Zhu Q-Y, Zhu C-Q (2010a) Astaxanthin upregulates heme oxygenase-1 expression through ERK1/2 pathway and its protective effect against beta-amyloid-induced cytotoxicity in SH-SY5Y cells. Brain Res 1360:159–167CrossRefGoogle Scholar
  25. Wang W, Shi J, Xie WF (2010b) Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int 30:741–749CrossRefGoogle Scholar
  26. Wong RS (2011) Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 30:87CrossRefGoogle Scholar
  27. Xu Y, Wen Z, Xu Z (2009) Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an antiangiogenic mechanism. Anticancer Res 29:5103–5109Google Scholar
  28. Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW, Szeto HH (2004) Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 279:34682–34690CrossRefGoogle Scholar
  29. Zuhorn IS, Kalicharan R, Hoekstra D (2002) Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent Clathrin-mediated pathway of endocytosis. J Biol Chem 277:18021–18028CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Biochemistry Division, Chemistry Department, Faculty of ScienceTanta UniversityTantaEgypt
  2. 2.Zoology Department, Faculty of ScienceTanta UniversityTantaEgypt
  3. 3.Department of Histology, Faculty of MedicineKafrelsheikh UniversityKafr El SheikhEgypt
  4. 4.Clinical Pharmacy Department, Faculty of PharmacyAlazhar UniversityCairoEgypt
  5. 5.Anatomy Department, Faculty Veterinary MedicineKafrelsheikh UniversityKafr El SheikhEgypt

Personalised recommendations